Heptanoate as a neural fuel: Energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 2, 2013, Pages 175-182

  Marin Valencia, Isaac ^a   Good, Levi B ^a   Ma, Qian ^a   Malloy, Craig R ^a,b   Pascual, Juan M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

glucose; glutamine; nuclear magnetic resonance; transporter

Indexed keywords

ACETYL COENZYME A; AMINO ACID; CARBON 13; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUTAMIC ACID; GLUTAMINE; HEPTANOIC ACID DERIVATIVE; NEUROTRANSMITTER; PROPIONYL COENZYME A; SUCCINYL COENZYME A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CARBON NUCLEAR MAGNETIC RESONANCE; CELL METABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; ENERGY; GLIA CELL; GLUCOGENESIS; GLUCOSE BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYL COENZYME A; ANIMALS; ANTICONVULSANTS; BRAIN; BRAIN CHEMISTRY; ENERGY METABOLISM; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUTAMINE; HEPTANOATES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, TRANSGENIC; PYRUVIC ACID; SEIZURES; TRIGLYCERIDES;

EID: 84873411637     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.151     Document Type: Article

References (41)

1. Schurr A. Neuronal energy requirements. In: Walz W (ed) The Neuronal Environment: Brain Homeostasis in Health and Disease. Humana Press: New Jersey, 2002, pp 25.
2. Leary LD, Wang D, Nordli Jr. DR, Engelstad K, De Vivo DC. Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome. Epilepsia 2003; 44: 701-707.
3. Pascual JM, Campistol J, Gil-Nagel A. Epilepsy in inherited metabolic disorders. Neurologist 2008; 14(6 Suppl 1): S2-S14.
4. Wang D, Pascual JM, Yang H, Engelstad K, Jhung S, Sun RP et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 2005; 57: 111-118.
5. Wang D, Pascual JM, Yang H, Engelstad K, Mao X, Cheng J et al. A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet 2006; 15: 1169-1179.
6. Gruetter R, Seaquist ER, Ugurbil K. A mathematical model of compartmentalized neurotransmitter metabolism in the human brain. Am J Physiol Endocrinol Metab 2001; 281: E100-112.
7. Yudkoff M, Daikhin Y, Melo TM, Nissim I, Sonnewald U. The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. Annu Rev Nutr 2007; 27: 415-430.
8. Bough K. Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet. Epilepsia 2008; 49(Suppl 8): 91-93.
9. Roe CR, Sweetman L, Roe DS, David F, Brunengraber H. Treatment of cardio-myopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 2002; 110: 259-269.
10. Roe CR, Mochel F. Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential. J Inherit Metab Dis 2006; 29: 332-340.
11. Willis S, Stoll J, Sweetman L, Borges K. Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. Neurobiol Dis 2010; 40: 565-572.
12. Marin-Valencia I, Roe CR, Pascual JM. Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis. Mol Genet Metab 2010; 101: 9-17.
13. Borges K, Sonnewald U. Triheptanoin-A medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment? Epilepsy Res 2011.
14. Marin-Valencia I, Good LB, Ma Q, Duarte J, Bottiglieri T, Sinton CM et al. Glut1 deficiency (G1D): epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype. Neurobiol Dis 2012; 48: 92-101.
15. Marin-Valencia I, Good LB, Ma Q, Jeffrey FM, Malloy CR, Pascual JM. High-resolution detection of (1)(3)C multiplets from the conscious mouse brain by ex vivo NMR spectroscopy. J Neurosci Methods 2012; 203: 50-55.
16. Marin-Valencia I, Good LB, Ma Q, Malloy CR, Patel MS, Pascual JM. Cortical metabolism in pyruvate dehydrogenase deficiency revealed by ex vivo multiplet (13)C NMR of the adult mouse brain. Neurochem Int 2012; 100: 239-244.
17. Gu L, Zhang GF, Kombu RS, Allen F, Kutz G, Brewer WU et al. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipo-lysis, glucose production, and liver acyl-CoA profile. Am J Physiol Endocrinol Metab 2010; 298: E362-371.
18. Suh JM, Zeve D, McKay R, Seo J, Salo Z, Li R et al. Adipose is a conserved dosage-sensitive antiobesity gene. Cell Metab 2007; 6: 195-207.
19. Malloy ADSaCM. 13C Isotopomer analysis of glutamate. A NMR method to probe metabolic pathways intersecting in the citric acid cycle. In Berliner P-MLR L. J (ed) Biological Magnetic Resonance. In Vivo Carbon-13 NMR vol. 15. Kluwer Academic/Plenum Publishers: New York, 1998, pp 59-97.
20. Roe CR, Yang BZ, Brunengraber H, Roe DS, Wallace M, Garritson BK. Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy. Neurology 2008; 71: 260-264.
21. Zhang GF, Kombu RS, Kasumov T, Han Y, Sadhukhan S, Zhang J et al. Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl- CoAs. J Biol Chem 2009; 284: 33521-33534.
22. Kombu RS, Brunengraber H, Puchowicz MA. Analysis of the citric acid cycle intermediates using gas chromatography-mass spectrometry. Methods Mol Biol 2011; 708: 147-157.
23. Kinman RP, Kasumov T, Jobbins KA, Thomas KR, Adams JE, Brunengraber LN et al. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. Am J Physiol Endocrinol Metab 2006; 291: E860-866.
24. Leclerc J, Des Rosiers C, Montgomery JA, Brunet J, Ste-Marie L, Reider MW et al. Metabolism of R-beta-hydroxypentanoate and of beta-ketopentanoate in conscious dogs. Am J Physiol 1995; 268(3 Pt 1): E446-452.
25. Previs SF, Hallowell PT, Neimanis KD, David F, Brunengraber H. Limitations of the mass isotopomer distribution analysis of glucose to study gluconeogenesis. Heterogeneity of glucose labeling in incubated hepatocytes. J Biol Chem 1998; 273: 16853-16859.
26. Fernandez CA, Des Rosiers C, Previs SF, David F, Brunengraber H. Correction of 13C mass isotopomer distributions for natural stable isotope abundance. J Mass Spectrom 1996; 31: 255-262.
27. Pascual JM, Van Heertum RL, Wang D, Engelstad K, De Vivo DC. Imaging the metabolic footprint of Glut1 deficiency on the brain. Ann Neurol 2002; 52: 458-464.
28. Pascual JM, Wang D, Hinton V, Engelstad K, Saxena CM, Van Heertum RL et al. Brain glucose supply and the syndrome of infantile neuroglycopenia. Arch Neurol 2007; 64: 507-513.
29. Fogarty M, Grist M, Gelman D, Marin O, Pachnis V, Kessaris N. Spatial genetic patterning of the embryonic neuroepithelium generates GABAergic interneuron diversity in the adult cortex. J Neurosci 2007; 27: 10935-10946.
30. Mochel F, DeLonlay P, Touati G, Brunengraber H, Kinman RP, Rabier D et al. Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab 2005; 84: 305-312.
31. Roe CR, Bottiglieri T, Wallace M, Arning E, Martin A. Adult Polyglucosan Body Disease (APBD): anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways. Mol Genet Metab 2010; 101: 246-252.
32. Martinez-Hernandez A, Bell KP, Norenberg MD. Glutamine synthetase: glial localization in brain. Science 1977; 195: 1356-1358.
33. Warringa RA, van Berlo MF, Klein W, Lopes-Cardozo M. Cellular location of glu-tamine synthetase and lactate dehydrogenase in oligodendrocyte-enriched cultures from rat brain. J Neurochem 1988; 50: 1461-1468.
34. Nguyen NH, Morland C, Gonzalez SV, Rise F, Storm-Mathisen J, Gundersen V et al. Propionate increases neuronal histone acetylation, but is metabolized oxidatively by glia. Relevance for propionic acidemia. J Neurochem 2007; 101: 806-814.
35. Ebert D, Haller RG, Walton ME. Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J Neurosci 2003; 23: 5928-5935.
36. Guzman M, Blazquez C. Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol Metab 2001; 12: 169-173.
37. Auestad N, Korsak RA, Morrow JW, Edmond J. Fatty acid oxidation and keto-genesis by astrocytes in primary culture. J Neurochem 1991; 56: 1376-1386.
38. Pardo B, Rodrigues TB, Contreras L, Garzón M, Llorente-Folch I, Kobayashi K et al. Brain glutamine synthesis requires neuronal-born aspartate as amino donor for glial glutamate formation. J Cereb Blood Flow Metab 2011; 31: 90-101.
39. Ullner PM, Di Nardo A, Goldman JE, Schobel S, Yang H, Engelstad K et al. Murine Glut-1 transporter haploinsufficiency: postnatal deceleration of brain weight and reactive astrocytosis. Neurobiol Dis 2009; 36: 60-69.
40. Eddleston M, Mucke L. Molecular profile of reactive astrocytes- implications for their role in neurologic disease. Neuroscience 1993; 54: 15-36.
41. Bak LK, Iversen P, Sorensen M, Keiding S, Vilstrup H, Ott P et al. Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia. Metab Brain Dis 2009; 24: 135-145.